Expression of Heat Shock Protein 105 in Cutaneous Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics
Meng Jia,Feng-Zeng Li,Qian Ye,Ke-Jun Chen,Sheng Fang
DOI: https://doi.org/10.2147/CCID.S308000
2021-06-14
Abstract:Meng Jia, Feng-Zeng Li, Qian Ye, Ke-Jun Chen, Sheng Fang Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China Correspondence: Sheng Fang Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China Email Background: Heat shock proteins (HSPs), a group of heat stress proteins, are characterized by highly conserved properties. Malignant transformation is a cellular stress, and the expression of HSPs may be affected during this process. Heat shock protein 105 (HSP105) is a protective protein that has long been observed in many cancer types, but little attention has been given to cutaneous squamous cell carcinoma (CSCC). As such, the objectives of this study were to observe the expression of HSP105 on CSCC and evaluate its correlation with clinicopathological characteristics. Methods: This retrospective study enrolled 60 patients with CSCC. The patients' clinical data, including sex, age, tumor location, tumor type, and degree of pathological differentiation, were collected. The expression of HSP105 was measured by Western blot and immunohistochemical staining. Results: HSP105 expression was decreased in CSCC (HSCORE=0.65 (0.30, 1.98)) compared with normal skin (HSCORE=2.20 (1.50, 2.80)) (P< 0.001). These results were consistent with the Western blot analysis. HSP105 immunostaining of Bowen disease (HSCORE=1.28 (1.08, 2.40)) revealed higher expression than in verrucous carcinoma (HSCORE=0.30 (0.23, 0.85)), keratoacanthoma (HSCORE=0.53 (0.29, 0.93)) and acantholytic squamous cell carcinoma (HSCORE=0.53 (0.41, 0.68) (P< 0.01)). Poorly differentiated CSCC showed significantly higher expression of HSP105. Conclusion: Our study reveals for the first time that the expression of HSP105 is decreased in CSCC. We suggest that the molecular mechanisms underlying the differential expression of HSP deserve a more rigorous future study, the results of which might explain its role in carcinogenesis and its potential as a target for selective tumor therapy. Keywords: heat shock protein 105, cutaneous, squamous cell carcinoma, expression The incidence of cutaneous squamous cell carcinoma (CSCC), one of the most common skin cancers, is second only to basal cell carcinoma (BCC). Although it is recognized that UV exposure is a preventable risk factor for CSCC, from 1992 to 2012, the number of keratinocyte carcinomas, including CSCC and BCC, in the US population increased by 100%. 1 Heat shock proteins (HSPs), major components of the cellular proteoprotection system, are involved in tumor cell proliferation and the prevention of apoptosis. HSPs are characterized by diverse intracellular localization and functional differentiation. When organisms are stimulated by external conditions, HSPs participate in the folding, assembly and transportation of newly synthesized proteins and prevent denaturation or nonspecific aggregation of improperly folded proteins. 2 HSP105, a member of the HSP110 family, is a mammalian stress protein with high molecular weight that is released in response to a variety of stress factors, such as infection, tumors, heat and ischemia. 3 , 4 Previous research has shown that HSP105 is overexpressed in a variety of human tumors. 5 Nooshin et al showed the association between HSP27 and HSP105 and prognosis in tongue SCC, and HSP105 is a promising agent for cancer immunotherapy. 6 Souzana et al studied the expression of HSP105 in oral SCCs, and their results suggested that the overexpression of HSP105 may be a prognostic factor for malignancy in oral SCC. 7 Muchemwa et al reported that tumors overexpressing HSP105 are ideal candidates for vaccination with HSP105-derived peptides or DNA. 8 However, an association between the level of HSP105 expression and CSCC has thus far been lacking. We therefore aimed to study HSP105 expression in CSCC and evaluate its correlation with clinicopathological characteristics. Ethics approval was granted by the First Affiliated Hospital of Chongqing Medical University & Ethics unit (No 2021-004). A retrospective review was conducted of patients seen at the First Affiliated Hospital of Chongqing Medical University, Chongqing, China, between January 2016 and October 2020. Patients were eligible to participate if they were diagnosed with CSCC. Clinical data were collected from medical records. The First Affiliated Hospital of Chongqing Medical University Ethi -Abstract Truncated-